Redcare Pharmacy stock closes at EUR 74.80 as company lifts guidance
Published on 10/17/2026 at 10:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGuidance and reporting dates
- On September 28, 2026, Redcare Pharmacy raised its full-year revenue growth guidance to 16 to 18 percent.
- Redcare Pharmacy stock closed at EUR 74.80 on Xetra on October 16, 2026.
- The next Xetra session is scheduled for October 19, 2026.
Redcare Pharmacy stock closed at EUR 74.80 on Xetra on October 16, 2026. On September 28, 2026, Redcare Pharmacy announced that it had raised its full-year 2026 total revenue growth guidance to 16 to 18 percent, from 15 to 17 percent previously, according to the company's investor relations release.
Market context: Market report DAX.
Weekend trading at Lang & Schwarz
The next price is shown from the start of trading by the continuously updated real-time quote of Redcare Pharmacy stock.
The week in figures
The Xetra closing price on October 16, 2026, was EUR 74.80. No additional weekly price figures are included here.
Company guidance
Redcare Pharmacy said its updated full-year 2026 guidance includes Rx revenue in Germany of EUR 730 million to EUR 760 million, compared with the previously guided range of EUR 680 million to EUR 720 million. The company kept its adjusted EBITDA margin guidance at 2.5 percent to 3.0 percent, according to the company announcement.
Dates of the coming week
The next Xetra session is scheduled for October 19, 2026. Redcare Pharmacy plans to publish its interim statement for the third quarter of 2026 on October 29, 2026, according to the investor relations release.
